SCHEMBL7362489

SCHEMBL7362489

CCCCn1cnc2c(Oc3ccc(F)cc3)nc(Nc3ccccc3)nc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNE1 P24864 5/20 0.49
CDK2 P24941 5/20 0.49
PDGFRA P16234 4/20 0.49
CTSL P07711 2/20 0.43
KCNH3 Q9ULD8 1/20 0.41
CDK1 P06493 4/20 0.41
CCNB2 O95067 1/20 0.41
CCNE2 O96020 1/20 0.41
FGFR1 P11362 1/20 0.41
CDK4 P11802 1/20 0.41
CCNB1 P14635 1/20 0.41
CCNA2 P20248 1/20 0.41
FGFR2 P21802 1/20 0.41
FGFR4 P22455 1/20 0.41
FGFR3 P22607 1/20 0.41
CCND1 P24385 1/20 0.41
CCND2 P30279 1/20 0.41
CCND3 P30281 1/20 0.41
CCNA1 P78396 1/20 0.41
CCNB3 Q8WWL7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7663415 0.96 PDGFRA (0.47) CCNE1CDK2PDGFRACTSLKCNH3
SCHEMBL7363934 0.93 CCNE1 (0.52) CCNE1CDK2PDGFRACTSLCDK1
SCHEMBL7670599 0.91 CTSL (0.42) CCNE1CDK2PDGFRACTSLKCNH3
SCHEMBL7672226 0.88 CDK1 (0.45) CCNE1CDK2PDGFRACTSLKCNH3
SCHEMBL7661496 0.87 CTSL (0.41) CCNE1CDK2PDGFRACTSLKCNH3
SCHEMBL7670076 0.86 PDGFRA (0.47) CCNE1CDK2PDGFRACTSLKCNH3
SCHEMBL7358873 0.85 CTSL (0.46) CCNE1CDK2PDGFRACTSLKCNH3
SCHEMBL7661515 0.84 CCNE1 (0.54) CCNE1CDK2PDGFRACTSLCDK1
SCHEMBL7668634 0.84 CCNE1 (0.54) CCNE1CDK2PDGFRACTSLCDK1
SCHEMBL7667654 0.83 CCNE1 (0.53) CCNE1CDK2PDGFRACTSLKCNH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6414147-B1 DIAGNOSIS AND TREATMENT OF ANXIETY, DEPRESSION, SLEEP AND SEIZURE DISORDERS, DOWN'S SYNDROME, OVERDOSE WITH BENZODIAZEPINE DRUGS, AND FOR ENHANCEMENT OF MEMORY NEUROGEN CORPORATION 2002-07-02 US claimed
US-6414147-B1 DIAGNOSIS AND TREATMENT OF ANXIETY, DEPRESSION, SLEEP AND SEIZURE DISORDERS, DOWN'S SYNDROME, OVERDOSE WITH BENZODIAZEPINE DRUGS, AND FOR ENHANCEMENT OF MEMORY NEUROGEN CORPORATION 2002-07-02 US disclosed
WO-2000037471-A1 2-AMINO-9-ALKYLPURINES: GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 2000-06-29 WO disclosed